<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Identifying newborns with critical congenital heart disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Identifying newborns with critical congenital heart disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Identifying newborns with critical congenital heart disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carolyn A Altman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David R Fulton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 01, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2707561"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Congenital heart disease (CHD) is the most common type of congenital anomaly, with an overall prevalence of approximately 1 percent [<a href="#rid1">1-3</a>]. Critical CHD, defined as lesions requiring surgery or catheter-based intervention in the first year of life (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>), accounts for approximately 25 percent of CHD [<a href="#rid4">4</a>]. Many newborns with critical CHD are diagnosed prenatally or are identified soon after birth (eg, due to symptoms or positive pulse oximetry screening). However, some affected infants are not diagnosed until after discharge from the birth hospitalization [<a href="#rid5">5-8</a>]. In infants with critical cardiac lesions, the risk of morbidity and mortality increases when there is a delay in diagnosis and timely referral to a tertiary center with expertise in treating these patients [<a href="#rid9">9-12</a>].</p><p>The clinical presentation and initial diagnostic evaluation of suspected critical CHD in the newborn will be reviewed here. Pulse oximetry screening and its role in the diagnosis and management of cyanotic CHD are discussed in greater detail separately [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a> and  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn"</a>.)</p><p class="headingAnchor" id="H608466411"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>The following terms are used to characterize CHD in this discussion:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cyanotic CHD</strong> – Cyanotic CHD includes lesions that allow circulation of deoxygenated blood in the systemic circulation via intracardiac or extracardiac shunting (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/5780.html" rel="external">"Cardiac causes of cyanosis in the newborn"</a> and  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ductal-dependent CHD</strong> – Ductal-dependent congenital heart lesions are dependent upon a patent ductus arteriosus (PDA) (<a class="graphic graphic_figure graphicRef65828" href="/d/graphic/65828.html" rel="external">figure 1</a>) to supply pulmonary or systemic blood flow or to allow adequate mixing between parallel circulations. In critical right heart obstructive lesions, the PDA is necessary to supply blood flow to the lungs; in critical left heart lesions, the PDA supplies systemic circulation; and in parallel circulations (eg, transposition of the great arteries), bidirectional flow in the PDA allows mixing between oxygenated and deoxygenated circuits (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>). Many, but not all, cyanotic congenital heart defects are ductal-dependent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Critical CHD</strong> – Critical CHD refers to lesions requiring surgery or catheter-based intervention in the first year of life (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>). This category includes ductal-dependent and cyanotic lesions as well as forms of CHD that may not require surgery in the neonatal period but still require intervention in the first year of life, such as a large ventricular septal defect or an atrioventricular canal defect (or atrioventricular septal defect). Critical CHD accounts for approximately 25 percent of all CHD [<a href="#rid4">4</a>].</p><p></p><p class="headingAnchor" id="H2707568"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H814062945"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>The reported prevalence of CHD ranges from 6 to 13 per 1000 live births [<a href="#rid14">14-20</a>]. The variability in these estimates is primarily due to the methods to detect CHD in the different studies (ie, fetal echocardiography versus postnatal referral to a cardiac center) [<a href="#rid18">18,21</a>].</p><p>Critical CHD accounts for approximately 25 percent of all CHD [<a href="#rid4">4</a>]. In infants with critical CHD, the risk of morbidity and mortality increases when there is a delay in diagnosis and timely referral to a tertiary center with expertise in treating these patients [<a href="#rid10">10,11</a>]. CHD is the leading cause of perinatal and infant death from a congenital anomaly, although outcomes have significantly improved with the advancement of corrective or palliative interventions [<a href="#rid1">1,17,22-24</a>].</p><p>The most common congenital cardiac defect is a bicuspid aortic valve, with a prevalence estimated between 0.5 and 2 percent; however, as an isolated lesion, it is rarely diagnosed in infancy [<a href="#rid25">25-27</a>]. The next most common defects are ventricular septal defects and secundum atrial septal defects (ASDs), with a prevalence of 4 and 2 per 1000 live births, respectively [<a href="#rid13">13,16,28,29</a>]. Tetralogy of Fallot (<a class="graphic graphic_figure graphicRef82493" href="/d/graphic/82493.html" rel="external">figure 2</a>) is the most common cyanotic CHD (0.5 per 1000 births) [<a href="#rid16">16,30</a>].</p><p class="headingAnchor" id="H608466476"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>The following factors are associated with an increased risk of CHD and should heighten the clinician's suspicion for CHD (<a class="graphic graphic_table graphicRef103088" href="/d/graphic/103088.html" rel="external">table 2</a>) [<a href="#rid31">31</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prematurity</strong> – The risk of CHD (excluding isolated patent ductus arteriosus [PDA]) is two- to threefold higher in preterm (gestational age &lt;37 weeks) compared with term infants [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Family history</strong> – The risk of CHD in infants with first-degree relatives (ie, parents or siblings) who have nonsyndromic isolated CHD is estimated to be three- to fourfold higher than that of the general population [<a href="#rid32">32-34</a>]. The risk varies considerably depending on the type of CHD and whether the mother, father, sibling, or multiple family members are affected [<a href="#rid34">34-37</a>]. Left heart obstructive lesions carry a higher risk of recurrence; whereas D-transposition of the great arteries carries a low risk of recurrence (<a class="graphic graphic_table graphicRef103088" href="/d/graphic/103088.html" rel="external">table 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetic syndromes and extracardiac abnormalities</strong> – Genetic syndromes and extracardiac abnormalities are common in patients with CHD. In a population-based study, chromosomal defects were detected in 7 percent of patients with CHD and extracardiac anomalies in 22 percent [<a href="#rid33">33</a>]. Many genetic syndromes are associated with an increased risk of CHD (<a class="graphic graphic_table graphicRef81423" href="/d/graphic/81423.html" rel="external">table 3</a>) [<a href="#rid38">38,39</a>]. Some genetic conditions may only be identified after the diagnosis of CHD is made upon further investigation under the direction of a cardiac geneticist and genetic counselor.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Maternal factors</strong> – Maternal conditions that increase the risk of CHD include diabetes mellitus, hypertension, obesity, phenylketonuria, thyroid disorders, systemic connective tissue disorders, and epilepsy [<a href="#rid20">20,40</a>]. In addition, drugs taken during pregnancy (eg, <a class="drug drug_pediatric" data-topicid="12702" href="/d/drug information/12702.html" rel="external">phenytoin</a> and retinoic acid) as well as smoking and/or alcohol use can be associated with cardiac defects [<a href="#rid41">41-45</a>]. (See  <a class="medical medical_review" href="/d/html/6755.html" rel="external">"Congenital heart disease: Prenatal screening, diagnosis, and management", section on 'Indications for echocardiography'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fertility treatment</strong> – Assisted reproductive technology (ART) and non-ART fertility treatments have been linked to increased risk of septal defects and cyanotic CHD [<a href="#rid46">46,47</a>]. (See  <a class="medical medical_review" href="/d/html/133130.html" rel="external">"Assisted reproductive technology: Infant and child outcomes"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>In utero infection</strong> – CHD may result from congenital infections (eg, rubella). Maternal influenza or flu-like illness during pregnancy is also associated with increased risk of CHD [<a href="#rid48">48</a>]. Congenital cardiomyopathy may result from infection with cytomegalovirus, coxsackie, herpes virus 6, parvovirus B19, herpes simplex, toxoplasmosis, and possibly HIV. (See  <a class="medical medical_review" href="/d/html/15870.html" rel="external">"Seasonal influenza and pregnancy"</a> and  <a class="medical medical_review" href="/d/html/6011.html" rel="external">"Overview of TORCH infections"</a>.)</p><p></p><p class="headingAnchor" id="H190050033"><span class="h1">TIMING OF DIAGNOSIS</span></p><p class="headingAnchor" id="H956706601"><span class="h2">Prenatal diagnosis</span><span class="headingEndMark"> — </span>Clinicians skilled at fetal echocardiography are able to identify most critical congenital heart defects. Referrals for fetal echocardiography are typically prompted by the presence of risk factors or suspicion on obstetrical anatomy ultrasounds, typically performed in the second trimester. The International Society for Ultrasound in Obstetrics and Gynecology (ISUOG) in 2013 recommended that antenatal ultrasound include assessment of the outflow tracts in addition to the four-chamber views to assist in better recognition of CHD [<a href="#rid49">49</a>]. CHD lesions involving abnormal outflow tracts (including tetralogy of Fallot (<a class="graphic graphic_figure graphicRef82493" href="/d/graphic/82493.html" rel="external">figure 2</a>), double-outlet right ventricle, and transposition of the great arteries (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>)) are particularly at risk for not being identified. Coarctation of the aorta (COA) (<a class="graphic graphic_figure graphicRef103747" href="/d/graphic/103747.html" rel="external">figure 4</a>) can be difficult to definitively diagnose prenatally, regardless of the technique. (See  <a class="medical medical_review" href="/d/html/5760.html" rel="external">"Clinical manifestations and diagnosis of coarctation of the aorta", section on 'Prenatal diagnosis'</a>.)</p><p>Whether the expanded prenatal screening recommendations of the ISUOG have improved prenatal detection of critical CHD is uncertain. Studies performed in the era prior to publication of these guidelines indicate that less than one-half of patients with critical congenital heart defects were routinely identified [<a href="#rid11">11,50-52</a>]. One study found that the rate of prenatal detection of critical CHD increased from 44 percent in 2007 to 69 percent in 2013 [<a href="#rid51">51</a>]. However, other studies have shown more mixed results, with detection rates of only 50 to 60 percent in the era following the 2013 ISUOG guidelines [<a href="#rid53">53-55</a>].</p><p>In addition, social determinants of health impact prenatal diagnosis rates [<a href="#rid56">56</a>]. In one study, lower economic status, rural residence, and Hispanic ethnicity were associated with lower prenatal detection of two critical CHD lesions (transposition of the great arteries and hypoplastic left heart syndrome) [<a href="#rid57">57</a>].</p><p>These studies highlight the importance of remaining vigilant for postnatal diagnoses.</p><p>Prenatal sonographic screening for CHD is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/6755.html" rel="external">"Congenital heart disease: Prenatal screening, diagnosis, and management"</a>.)</p><p class="headingAnchor" id="H608469901"><span class="h2">Postnatal diagnosis</span><span class="headingEndMark"> — </span>Infants with critical CHD may present during the birth hospitalization, often with serious and life-threatening clinical findings that require immediate intervention [<a href="#rid19">19</a>]. However, some infants with CHD may appear normal on routine examination and signs of critical CHD may not be apparent until after discharge [<a href="#rid19">19</a>]. The timing of presentation varies with the underlying lesion and its dependence upon a patent ductus arteriosus (PDA) (<a class="graphic graphic_figure graphicRef65828" href="/d/graphic/65828.html" rel="external">figure 1</a> and <a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>). Prior to the routine use of pulse oximetry screening, approximately 30 percent of patients with critical CHD were discharged from the birth hospitalization undiagnosed [<a href="#rid58">58</a>].</p><p>The most commonly reported delayed diagnoses are COA (<a class="graphic graphic_figure graphicRef103747" href="/d/graphic/103747.html" rel="external">figure 4</a>), interrupted aortic arch (<a class="graphic graphic_figure graphicRef103748" href="/d/graphic/103748.html" rel="external">figure 5</a>), aortic stenosis, hypoplastic left heart syndrome (<a class="graphic graphic_figure graphicRef82280" href="/d/graphic/82280.html" rel="external">figure 6</a>), transposition of the great arteries (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>), pulmonary valve stenosis, and tetralogy of Fallot (<a class="graphic graphic_figure graphicRef82493" href="/d/graphic/82493.html" rel="external">figure 2</a>) [<a href="#rid58">58,59</a>]. Pulse oximetry screening can identify infants with some, but not all, of these lesions. (See  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry", section on 'Definition and targeted lesions'</a>.)</p><p>In patients with ductal-dependent lesions, closure of the PDA within the first few days of life can precipitate rapid clinical deterioration, with potentially life-threatening consequences (ie, severe metabolic acidosis, cardiogenic shock, cardiac arrest, seizures, other end-organ injury) [<a href="#rid60">60</a>]. For infants with critical CHD who are not diagnosed during the birth hospitalization, the risk of mortality is as high as 30 percent [<a href="#rid10">10,11,61</a>].</p><p class="headingAnchor" id="H2707575"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Neonates with critical CHD can present during their birth hospitalization with serious and life-threatening manifestations including <strong>shock</strong>, <strong>cyanosis</strong>, <strong>tachypnea</strong>, and/or symptoms of<strong> pulmonary edema</strong>. However, some infants with CHD may appear normal on routine examination and signs of critical CHD may not be apparent.</p><p>Urgent consultation/referral to a pediatric cardiologist should be made when CHD is suspected in neonates who present with shock, cyanosis, or pulmonary edema [<a href="#rid62">62</a>].</p><p>Infants with ductal-dependent lesions are at increased risk for death and significant morbidity unless interventions are initiated to maintain patency of the ductus arteriosus (ie, prostaglandin therapy), ensure adequate mixing of deoxygenated and oxygenated blood, and/or relieve obstructed blood flow. (See  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Initial management'</a>.)</p><p class="headingAnchor" id="H1086346679"><span class="h2">Early presentation</span><span class="headingEndMark"> — </span>Neonates who present with symptomatic CHD in the early newborn period typically present with shock, cyanosis, or respiratory symptoms (or a combination of these).</p><p class="headingAnchor" id="H2707582"><span class="h3">Shock</span><span class="headingEndMark"> — </span>Some infants with critical CHD will present during the neonatal hospitalization with shock. Most commonly, this is seen in infants with unsuspected critically obstructive left heart lesions (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>), including:</p><p class="bulletIndent1"><span class="glyph">●</span>Hypoplastic left heart syndrome (<a class="graphic graphic_figure graphicRef82280" href="/d/graphic/82280.html" rel="external">figure 6</a>) (see  <a class="medical medical_review" href="/d/html/14370.html" rel="external">"Hypoplastic left heart syndrome: Anatomy, clinical features, and diagnosis"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Critical aortic valve stenosis (see  <a class="medical medical_review" href="/d/html/5775.html" rel="external">"Valvar aortic stenosis in children", section on 'Critical aortic stenosis'</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Critical coarctation of the aorta (COA) (<a class="graphic graphic_figure graphicRef103747" href="/d/graphic/103747.html" rel="external">figure 4</a>) (see  <a class="medical medical_review" href="/d/html/5760.html" rel="external">"Clinical manifestations and diagnosis of coarctation of the aorta"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Interrupted aortic arch (<a class="graphic graphic_figure graphicRef103748" href="/d/graphic/103748.html" rel="external">figure 5</a>)</p><p></p><p>Infants with these lesions may present with cardiogenic shock as the ductus arteriosus closes and systemic perfusion decreases. In these patients, initiation of prostaglandin E1 (generic drug name: <a class="drug drug_pediatric" data-topicid="13353" href="/d/drug information/13353.html" rel="external">alprostadil</a>) to reopen or maintain the ductus arteriosus is imperative. The use of prostaglandin E1 is discussed separately. (See  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Prostaglandin E1'</a>.)</p><p>Infants with total anomalous pulmonary venous return (TAPVR) (<a class="graphic graphic_figure graphicRef77375" href="/d/graphic/77375.html" rel="external">figure 7</a>) most commonly present with mild cyanosis and tachypnea. However, patients may present with cyanosis and shock if there is significant obstruction with a restrictive atrial communication. In these cases, systemic perfusion is impaired because all pulmonary venous return must traverse the restrictive atrial communication to reach the left heart and supply the systemic circulation. This is the rare instance in which these lesions might benefit from ductal patency (ie, prostaglandin therapy) until urgent surgical intervention can be achieved. If obstruction occurs within the pulmonary venous pathway itself, such as occurs commonly in TAPVR below the diaphragm, ductal patency is not of utility and the only effective management strategy is urgent surgical intervention. These patients present with severe cyanosis and marked pulmonary venous edema. (See  <a class="medical medical_review" href="/d/html/5767.html" rel="external">"Total anomalous pulmonary venous connection", section on 'Initial medical management'</a>.)</p><p>Cardiogenic shock must be differentiated from other causes of shock, such as sepsis. In newborns presenting with shock, features that suggest a cardiac etiology include cardiomegaly on chest radiograph, differential pulses, and lack of improvement or clinical deterioration in response to volume resuscitation [<a href="#rid63">63</a>]. (See <a class="local">'Differential diagnosis'</a> below and  <a class="medical medical_review" href="/d/html/5039.html" rel="external">"Neonatal shock: Etiology, clinical manifestations, and evaluation"</a>.)</p><p class="headingAnchor" id="H2707589"><span class="h3">Cyanosis</span><span class="headingEndMark"> — </span>Cyanosis is an important sign of critical CHD. Cyanosis is the bluish skin tone caused by the presence of approximately 3 to 5 g/dL of deoxygenated hemoglobin. However, cyanosis may not be readily clinically apparent in patients with mild desaturation (&gt;80 percent saturation) or anemia [<a href="#rid64">64</a>]. Cyanosis can be especially difficult to appreciate in darkly pigmented infants. Pulse oximetry is helpful to detect mild desaturation in patients with cyanotic CHD. (See  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn"</a> and  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a> and <a class="local">'Pulse oximetry screening'</a> below.)</p><p class="headingAnchor" id="H1312102076"><span class="h4">Ductal-dependent lesions</span><span class="headingEndMark"> — </span>In patients with ductal-dependent lesions (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>), closure of the patent ductus arteriosus (PDA) (<a class="graphic graphic_figure graphicRef65828" href="/d/graphic/65828.html" rel="external">figure 1</a>) in the first days of life can precipitate profound cyanosis by the following mechanisms:</p><p class="bulletIndent1"><span class="glyph">●</span>In patients with critically obstructive right heart lesions (eg, critical pulmonary valve stenosis, pulmonary atresia with intact ventricular septum (<a class="graphic graphic_figure graphicRef101334" href="/d/graphic/101334.html" rel="external">figure 8</a>)), pulmonary blood flow is supplied retrograde from the aorta via the PDA. Therefore, progressively severe cyanosis occurs as the ductus closes and blood flow to the lungs decreases. (See  <a class="medical medical_review" href="/d/html/87462.html" rel="external">"Pulmonary atresia with intact ventricular septum (PA/IVS)", section on 'Postnatal presentation'</a> and  <a class="medical medical_review" href="/d/html/14578.html" rel="external">"Pulmonic stenosis in infants and children: Clinical manifestations and diagnosis", section on 'Severe and critical pulmonic stenosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with critically obstructive left heart lesions (eg, hypoplastic left heart syndrome (<a class="graphic graphic_figure graphicRef82280" href="/d/graphic/82280.html" rel="external">figure 6</a>), critical aortic valve stenosis) who have an adequate atrial septal communication and a patent ductus will typically exhibit only minimal desaturation. For those with sufficient prograde flow across the aortic valve to supply the right subclavian artery fully, the preductal saturations can be normal. However, postductal saturations will be lower as right-to-left shunting at the PDA supplies the lower body circulation. However, upon closure of the ductus, systemic circulation is compromised, resulting in poor peripheral perfusion (ie, cardiogenic shock) and cyanosis. (See  <a class="medical medical_review" href="/d/html/14370.html" rel="external">"Hypoplastic left heart syndrome: Anatomy, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5775.html" rel="external">"Valvar aortic stenosis in children", section on 'Critical aortic stenosis'</a>.)</p><p></p><p class="bulletIndent1">Patients with critical left heart obstruction and a restrictive atrial communication will exhibit more profound cyanosis even with ductal patency [<a href="#rid65">65</a>]. A restrictive atrial communication results in decreased shunting of the oxygenated pulmonary venous return into the right heart, severe pulmonary edema, and pulmonary hypertension, all of which contribute to decreased systemic oxygenation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with parallel pulmonary and systemic circulations (eg, transposition of the great arteries (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>)) depend upon the PDA and atrial communications for mixing of oxygenated and deoxygenated blood. With ductal closure in the absence of an adequate atrial septal defect, profound cyanosis ensues. (See  <a class="medical medical_review" href="/d/html/14374.html" rel="external">"D-transposition of the great arteries (D-TGA): Anatomy, clinical features, and diagnosis", section on 'Presentation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neonates with Ebstein anomaly of the tricuspid valve may be cyanotic and ductal-dependent for pulmonary blood flow when there is a functional pulmonary atresia (<a class="graphic graphic_figure graphicRef79822" href="/d/graphic/79822.html" rel="external">figure 9</a>). (See  <a class="medical medical_review" href="/d/html/8146.html" rel="external">"Ebstein anomaly: Clinical manifestations and diagnosis"</a>.)</p><p></p><p>In patients with ductal-dependent lesions who present with severe cyanosis or shock, rapid initiation of prostaglandin E1 (generic drug name: <a class="drug drug_pediatric" data-topicid="13353" href="/d/drug information/13353.html" rel="external">alprostadil</a>) to reopen and maintain the patency of the ductus arteriosus is imperative. The use of prostaglandin E1 is discussed separately. (See  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Prostaglandin E1'</a>.)</p><p class="headingAnchor" id="H190049624"><span class="h4">Nonductal-dependent lesions</span><span class="headingEndMark"> — </span>Nonductal-dependent congenital heart defects that cause cyanosis include (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Total anomalous pulmonary venous connection (TAPVC) (<a class="graphic graphic_figure graphicRef77375" href="/d/graphic/77375.html" rel="external">figure 7</a>). (See  <a class="medical medical_review" href="/d/html/5767.html" rel="external">"Total anomalous pulmonary venous connection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Truncus arteriosus (<a class="graphic graphic_figure graphicRef83846" href="/d/graphic/83846.html" rel="external">figure 10</a>). (See  <a class="medical medical_review" href="/d/html/14588.html" rel="external">"Truncus arteriosus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tetralogy of Fallot (<a class="graphic graphic_figure graphicRef82493" href="/d/graphic/82493.html" rel="external">figure 2</a>) and tricuspid atresia (<a class="graphic graphic_figure graphicRef88605" href="/d/graphic/88605.html" rel="external">figure 11</a>) may or may not be ductal-dependent, depending upon the degree of right ventricular outflow tract obstruction and presence and size of a ventricular septal defect (in tricuspid atresia). (See  <a class="medical medical_review" href="/d/html/5769.html" rel="external">"Tetralogy of Fallot (TOF): Pathophysiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/14587.html" rel="external">"Tricuspid valve atresia"</a>.)</p><p></p><p class="headingAnchor" id="H956707786"><span class="h4">Differential cyanosis</span><span class="headingEndMark"> — </span>In differential cyanosis, the upper one-half of the body is pink and the lower one-half cyanotic. This can occur in infants with critical COA (<a class="graphic graphic_figure graphicRef103747" href="/d/graphic/103747.html" rel="external">figure 4</a>), interrupted arch (<a class="graphic graphic_figure graphicRef103748" href="/d/graphic/103748.html" rel="external">figure 5</a>), or critical aortic stenosis. In these lesions, the flow of deoxygenated blood through the ductus arteriosus supplies the lower one-half of the body's circulation, but oxygenated blood flow from the left heart supplies the upper body via the vessels proximal to the site of arch obstruction. It also occurs in newborns with structurally normal hearts who have persistent pulmonary hypertension. (See  <a class="medical medical_review" href="/d/html/5760.html" rel="external">"Clinical manifestations and diagnosis of coarctation of the aorta"</a> and  <a class="medical medical_review" href="/d/html/5775.html" rel="external">"Valvar aortic stenosis in children"</a> and  <a class="medical medical_review" href="/d/html/5045.html" rel="external">"Persistent pulmonary hypertension of the newborn (PPHN): Clinical features and diagnosis"</a>.)</p><p>To detect differential cyanosis, oxygen saturation should be measured in both the right hand (preductal) and either foot (postductal). It is preferable to use the right hand rather than left because the left subclavian artery arises close to the ductus arteriosus and some of its flow may come from the ductus and thus not accurately reflect preductal values. An oxygen saturation difference of &gt;3 percent is considered clinically meaningful. The differential effect may be reduced if there is also right-to-left shunting at the level of the foramen ovale or if there is left-to-right shunting across a coexisting ventricular septal defect. (See  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry", section on 'Approach to screening'</a>.)</p><p><strong>Reversed differential cyanosis</strong> is a rare finding that may occur in patients with transposition of the great arteries (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>) associated with either coarctation or pulmonary hypertension. In these infants, oxygen saturation is higher in the lower, rather than the upper, extremity as the most oxygenated flow is pumped by the left ventricle out to the pulmonary artery and thus across the PDA. (See  <a class="medical medical_review" href="/d/html/14374.html" rel="external">"D-transposition of the great arteries (D-TGA): Anatomy, clinical features, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1312101853"><span class="h4">Noncardiac causes</span><span class="headingEndMark"> — </span>Noncardiac conditions (eg, respiratory disorders, persistent pulmonary hypertension of the newborn) also can cause cyanosis and are differentiated from CHD by the history, cardiovascular examination, chest radiograph, echocardiography, and other laboratory testing. (See <a class="local">'Diagnostic approach'</a> below and <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H190050011"><span class="h3">Respiratory symptoms</span><span class="headingEndMark"> — </span>Tachypnea, increased work of breathing, and feeding difficulties can occur due to pulmonary edema from a rapid, massive increase in pulmonary blood flow as pulmonary vascular resistance falls shortly after delivery. This may occur in the following CHD defects:</p><p class="bulletIndent1"><span class="glyph">●</span>Truncus arteriosus (<a class="graphic graphic_figure graphicRef83846" href="/d/graphic/83846.html" rel="external">figure 10</a>) [<a href="#rid62">62</a>]. (See  <a class="medical medical_review" href="/d/html/14588.html" rel="external">"Truncus arteriosus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>TAPVC – TAPVC without obstruction generally results in mild to moderate symptoms of pulmonary overcirculation. In patients with obstruction within the extracardiac pulmonary venous channel or at a restrictive atrial septum, pulmonary venous edema predominates and generates more severe symptoms (<a class="graphic graphic_figure graphicRef77375" href="/d/graphic/77375.html" rel="external">figure 7</a>) [<a href="#rid66">66</a>]. (See  <a class="medical medical_review" href="/d/html/5767.html" rel="external">"Total anomalous pulmonary venous connection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>PDA in premature infants (<a class="graphic graphic_figure graphicRef65828" href="/d/graphic/65828.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/d/html/5057.html" rel="external">"Patent ductus arteriosus (PDA) in preterm infants: Clinical features and diagnosis"</a>.)</p><p></p><p>In patients with large ventricular septal defects, tachypnea, increased work of breathing, and feeding difficulties can occur due to pulmonary overcirculation from left-to-right shunting. This typically develops over the first four to six weeks of life as pulmonary vascular resistance falls. (See  <a class="medical medical_review" href="/d/html/5787.html" rel="external">"Isolated ventricular septal defects (VSDs) in infants and children: Anatomy, clinical features, and diagnosis"</a>.)</p><p>Infants with CHD and mild to moderate pulmonary overcirculation frequently have tachypnea without significant increased work of breathing at rest, sometimes referred to as "happy" or "comfortable" tachypnea. Infants may become more tachypneic with increasing pulmonary edema or during feeding, and they may exhibit grunting, nasal flaring, retractions, and head bobbing. Cardiac tachypnea in neonates may reflect increased pulmonary venous pressure or volume secondary to a large left-to-right shunt, pulmonary venous obstruction, or increased left ventricular end-diastolic pressure [<a href="#rid67">67</a>]. Tachypnea in heart failure is also thought to have a neurohormonal basis.</p><p>Respiratory signs and symptoms must be distinguished from those due to pulmonary disease. Cough and wheeze are more likely to be of pulmonary etiology, but they can occur with cardiovascular malformations. As an example, a tight vascular ring can compress the trachea, leading to wheezing, coughing, or stridor [<a href="#rid68">68,69</a>]. Lesions that cause elevated pulmonary venous pressure result in bronchial edema and bronchial compression by a distended left atrium and large left pulmonary artery [<a href="#rid67">67,68,70</a>]. These include large left-to-right shunts, mitral stenosis, left ventricular dysfunction (eg, from myocarditis), or pulmonary venous obstruction [<a href="#rid67">67,68,70,71</a>]. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>Persistently elevated respiratory rate (normal is 45 to 60 breaths per minute), increased respiratory effort at rest, or distress during feeding merit further investigation including careful physical examination, pulse oximetry, and chest radiography, as discussed below (see <a class="local">'Diagnostic approach'</a> below). If there are findings suggestive of CHD or if no clear pulmonary cause is identified on the initial evaluation, consultation or referral should be made to a pediatric cardiologist for echocardiography.</p><p class="headingAnchor" id="H1898782400"><span class="h2">Late presentation</span><span class="headingEndMark"> — </span>Some neonates with critical CHD are asymptomatic during the birth hospitalization and then develop signs and symptoms after discharge, typically by two weeks of age [<a href="#rid61">61,72,73</a>].</p><p class="headingAnchor" id="H3566437735"><span class="h3">Defects that may present late</span><span class="headingEndMark"> — </span>Prior to the introduction of routine pulse oximetry screening, the CHD defects that most frequently escaped diagnosis during the birth hospitalization included [<a href="#rid58">58,59,61</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Hypoplastic left heart syndrome (<a class="graphic graphic_figure graphicRef82280" href="/d/graphic/82280.html" rel="external">figure 6</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>COA (<a class="graphic graphic_figure graphicRef103747" href="/d/graphic/103747.html" rel="external">figure 4</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Interrupted aortic arch (<a class="graphic graphic_figure graphicRef103748" href="/d/graphic/103748.html" rel="external">figure 5</a>) </p><p class="bulletIndent1"><span class="glyph">●</span>Aortic stenosis</p><p class="bulletIndent1"><span class="glyph">●</span>Transposition of the great arteries (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonic stenosis</p><p class="bulletIndent1"><span class="glyph">●</span>Tetralogy of Fallot (<a class="graphic graphic_figure graphicRef82493" href="/d/graphic/82493.html" rel="external">figure 2</a>)</p><p></p><p>Pulse oximetry screening targets several of these lesions (transposition of the great arteries, tetralogy of Fallot, hypoplastic left heart syndrome), and so the frequency of missed diagnoses is likely to drop as pulse oximetry screening becomes widespread. However, it is important to recognize that infants with noncyanotic heart defects (including those with "pink" tetralogy of Fallot [ie, those with minimal pulmonary stenosis]) and some left heart obstructive lesions will not be identified by pulse oximetry screening [<a href="#rid74">74</a>]. (See  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p class="headingAnchor" id="H3803091061"><span class="h3">Signs and symptoms</span><span class="headingEndMark"> — </span>In affected newborn infants, parents/caregivers most commonly notice difficulty with feeding. This may be manifested by intake of a limited volume of milk or by feedings that are taking too long or are frequently interrupted by sleeping or resting, choking, gagging, and/or vomiting. Infants may have respiratory distress that is reported by parents as fast or hard breathing, breathing that is worse with feedings, or a persistent cough or wheeze.</p><p>Other manifestations include:</p><p class="bulletIndent1"><span class="glyph">●</span>Color changes, such as central cyanosis or persistent pallor</p><p class="bulletIndent1"><span class="glyph">●</span>Excessive, unexplained irritability</p><p class="bulletIndent1"><span class="glyph">●</span>Excessive sweating that is increased with feeding and may occur during sleep</p><p class="bulletIndent1"><span class="glyph">●</span>Poor weight gain</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased activity or excessive sleeping</p><p class="bulletIndent1"><span class="glyph">●</span>Delay in motor milestones [<a href="#rid75">75</a>]</p><p></p><p class="headingAnchor" id="H190052275"><span class="h1">DIAGNOSTIC APPROACH</span></p><p class="headingAnchor" id="H190052282"><span class="h2">During the birth hospitalization</span><span class="headingEndMark"> — </span>The presence or absence of symptoms in the neonate determines the extent of evaluation that should be performed during the birth hospitalization.</p><p class="headingAnchor" id="H190049968"><span class="h3">Symptomatic neonates</span><span class="headingEndMark"> — </span>Urgent consultation/referral to a pediatric cardiologist should be made when CHD is suspected in symptomatic neonates. The diagnostic evaluation includes the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination</strong> – A thorough physical examination should be performed with attention to findings suggestive of CHD (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a>), including abnormal precordial activity, abnormal heart sounds (eg, third heart sound [S3] gallop, click, or single second heart sound [S2]), pathologic murmurs (loud, harsh, pansystolic, diastolic, or loudest at upper left or right sternal border or apex), hepatomegaly, diminished or absent lower extremity pulses, and abnormal four extremity blood pressure (ie, blood pressure ≥10 mmHg higher in the arms than legs). (See <a class="local">'Physical examination'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulse oximetry</strong> – Pre- and postductal pulse oximetry to assess for cyanosis and differential cyanosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest radiograph</strong> – A chest radiograph can be helpful in differentiating between cardiac (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a>) and pulmonary disorders and should be obtained in neonates with cyanosis and/or respiratory symptoms.</p><p></p><p class="bulletIndent1">Chest radiograph is also useful in assessing for noncardiac causes of cyanosis, including pneumothorax, pulmonary hypoplasia, diaphragmatic hernia, pleural effusion, or airway disease.</p><p></p><p class="bulletIndent1">Cardiomegaly, dextrocardia, or an abnormal cardiac silhouette (eg, boot-shaped (<a class="graphic graphic_diagnosticimage graphicRef78997" href="/d/graphic/78997.html" rel="external">image 1</a>) in tetralogy of Fallot or egg-on-a-string pattern in D-transposition of the great arteries) may point towards the presence of CHD. Abnormal pulmonary vascular markings or side of the aortic arch may also suggest CHD. (See  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Chest radiograph'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrocardiogram (ECG)</strong> – Although the ECG may be normal in many cyanotic heart lesions during the neonatal period, some lesions are associated with specific patterns (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a>). (See  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Electrocardiogram'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyperoxia test</strong> – The hyperoxia test historically was used to help distinguish cardiac from pulmonary causes of cyanosis. With the advent of routine pulse oximetry screening for critical CHD and improved access to echocardiography, the hyperoxia test is usually <strong>not</strong> necessary. However, hyperoxia testing may be useful in some settings, particularly if echocardiography is not readily available.</p><p></p><p class="bulletIndent1">In the hyperoxia test, arterial oxygen tension (PaO<sub>2</sub>) is measured in the right radial artery (preductal) during the administration of room air and 100 percent oxygen. The relative changes in PaO<sub>2</sub> are used to differentiate the various cardiac and noncardiac causes of neonatal cyanosis (<a class="graphic graphic_table graphicRef54070" href="/d/graphic/54070.html" rel="external">table 5</a> and <a class="graphic graphic_table graphicRef75461" href="/d/graphic/75461.html" rel="external">table 6</a>). This test and its interpretation are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Hyperoxia test'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Echocardiography</strong> – Echocardiography provides a definitive diagnosis of CHD with information on cardiac anatomy and function. Echocardiography should be performed in consultation with a pediatric cardiologist if any of the following are present [<a href="#rid76">76</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Signs or symptoms concerning for critical CHD, including shock unresponsive to volume resuscitation, cyanosis or differential cyanosis, unexplained respiratory symptoms, or pulmonary edema. (See <a class="local">'Shock'</a> above and <a class="local">'Cyanosis'</a> above and <a class="local">'Respiratory symptoms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>ECG and/or chest radiograph findings suggestive of CHD (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Physical examination findings suggestive of CHD (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a>), including abnormal heart sounds (eg, S3 gallop, single S2, click), pathologic murmur, diminished or absent lower extremity pulses, abnormal four extremity blood pressures. (See <a class="local">'Physical examination'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Positive pulse oximetry screening (<a class="graphic graphic_algorithm graphicRef139676" href="/d/graphic/139676.html" rel="external">algorithm 1</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Genetic disorder or extracardiac malformation associated with cardiovascular malformations (<a class="graphic graphic_table graphicRef81423" href="/d/graphic/81423.html" rel="external">table 3</a>).</p><p></p><p class="bulletIndent1">Echocardiography can also be valuable in the diagnosis of some noncardiac causes of cyanosis (eg, persistent pulmonary hypertension of the newborn). (See  <a class="medical medical_review" href="/d/html/5045.html" rel="external">"Persistent pulmonary hypertension of the newborn (PPHN): Clinical features and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H270524543"><span class="h3">Asymptomatic neonates</span><span class="headingEndMark"> — </span>Early detection of neonatal CHD remains challenging because clinical findings may be subtle or absent immediately after birth. Studies have shown that pulse oximetry is an effective, though not infallible, screening measure. Thus, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the American College of Cardiology Foundation (ACCF) have recommended universal screening of all newborns with pulse oximetry to improve the recognition of CHD [<a href="#rid77">77</a>]. In addition to pulse oximetry screening, careful review of the history and examination of the infant remain imperative. (See <a class="local">'Pulse oximetry screening'</a> below and  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p class="headingAnchor" id="H353807075"><span class="h4">History</span><span class="headingEndMark"> — </span>The maternal history, prenatal history, and family history should be reviewed to identify possible risk factors that increase the likelihood of CHD (<a class="graphic graphic_table graphicRef103088" href="/d/graphic/103088.html" rel="external">table 2</a>). (See <a class="local">'Risk factors'</a> above.)</p><p>In addition to inquiring about CHD among family members, parents should be questioned about familial occurrence of cardiomyopathies, sudden death, or unexpected death in infancy or childhood that could potentially uncover genetic preponderance of potential congenital cardiac abnormalities within the family. (See  <a class="medical medical_review" href="/d/html/1036.html" rel="external">"Congenital long QT syndrome: Epidemiology and clinical manifestations"</a>.)</p><p class="headingAnchor" id="H353807113"><span class="h4">Physical examination</span><span class="headingEndMark"> — </span>Several studies have shown that the newborn examination alone fails to detect more than one-half of infants with heart disease [<a href="#rid61">61,72,78</a>]. However, subtle clinical findings may be detected that indicate underlying cardiac disease. The following discussion reviews the physical findings that may be seen in an infant with CHD; however, as noted above, findings may be absent in infants with ductal-dependent lesions if the ductus arteriosus remains patent during their birth hospitalization.</p><p>The following cardiovascular findings suggestive of CHD merit further evaluation and/or referral to clinicians with expertise in caring for neonates with CHD:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abnormal heart rate</strong> – In infants with heart rates that are higher or lower than the normal range of 90 to 160 beats per minute for neonates up to six days of age, ECG is initially performed to determine whether there is an arrhythmia and to guide further assessment and management [<a href="#rid79">79</a>]. (See  <a class="medical medical_review" href="/d/html/5766.html" rel="external">"Irregular heart rhythm (arrhythmias) in children"</a> and  <a class="medical medical_review" href="/d/html/6435.html" rel="external">"Approach to the child with tachycardia"</a> and  <a class="medical medical_review" href="/d/html/5759.html" rel="external">"Bradycardia in children"</a> and  <a class="medical medical_review" href="/d/html/5783.html" rel="external">"Clinical features and diagnosis of supraventricular tachycardia (SVT) in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abnormal precordial</strong> <strong>activity</strong> – Precordial palpation ascertains whether the heart is normally located on the left side of the chest. Dextrocardia is often associated with complex CHD. In addition, palpation may detect the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiac enlargement, which, in a newborn with respiratory symptoms, is more suggestive of cardiac than pulmonary disease [<a href="#rid80">80</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Ventricular impulse in the lower left parasternal area suggestive of right ventricular volume or pressure overload</p><p class="bulletIndent2"><span class="glyph">•</span>Increased apical activity suggestive of left ventricular volume or pressure overload</p><p class="bulletIndent2"><span class="glyph">•</span>Thrill due to outflow tract obstruction or a restrictive ventricular septal defect</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abnormal S2</strong> <strong>splitting</strong> – The S2 normally splits physiologically with inspiration and becomes single during expiration (<a class="graphic graphic_movie graphicRef104781" href="/d/graphic/104781.html" rel="external">movie 1</a>). The presence of S2 splitting reduces the likelihood of severe CHD; however, the newborn's rapid heart rate often makes it challenging to detect S2 splitting. Splitting is audible in 80 percent of normal newborns by 48 hours of age, usually when the heart rate is less than 150 beats per minute [<a href="#rid67">67,81</a>]. As an infant's heart is positioned more horizontally, splitting may be easier to hear along the mid- to lower sternal border than in children or adults. Listening may be facilitated by a gentle breath into the baby's face that may temporarily slow the heart rate. (See  <a class="medical medical_review" href="/d/html/103723.html" rel="external">"Approach to the infant or child with a cardiac murmur", section on 'Second heart sound'</a>.)</p><p></p><p class="bulletIndent1">A single S2 occurs in the following conditions (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aortic atresia</p><p class="bulletIndent2"><span class="glyph">•</span>Pulmonary atresia</p><p class="bulletIndent2"><span class="glyph">•</span>Truncus arteriosus (<a class="graphic graphic_figure graphicRef83846" href="/d/graphic/83846.html" rel="external">figure 10</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Severe pulmonary stenosis</p><p class="bulletIndent2"><span class="glyph">•</span>Tetralogy of Fallot (<a class="graphic graphic_figure graphicRef82493" href="/d/graphic/82493.html" rel="external">figure 2</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Conditions with pulmonary hypertension, as increased impedance in the pulmonary circuit causes early closure of the pulmonary valve, resulting in a single S2 (<a class="graphic graphic_movie graphicRef104785" href="/d/graphic/104785.html" rel="external">movie 2</a>)</p><p></p><p class="bulletIndent1">In the great arteries (transposition of the great arteries) (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>), the pulmonary artery is located posterior and directly behind the aorta; thus, the softer pulmonary component of the S2 is often inaudible.</p><p></p><p class="bulletIndent1">A widely or fixed split S2 occurs with atrial septal defect (ASD) (<a class="graphic graphic_movie graphicRef104783" href="/d/graphic/104783.html" rel="external">movie 3</a>) and other lesions associated with right ventricular volume overload or right-sided conduction delays (<a class="graphic graphic_movie graphicRef104782" href="/d/graphic/104782.html" rel="external">movie 4</a>). However, the absence of a widely split S2 in an infant does not rule out an ASD. The abnormal splitting may develop later with increasing volume of flow crossing the defect after pulmonary resistance has fallen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abnormal extra heart sounds</strong> – The following additional heart sounds may be associated with cardiac abnormalities. If any of these are heard, the infant should be evaluated by a pediatric cardiologist. (See  <a class="medical medical_review" href="/d/html/103723.html" rel="external">"Approach to the infant or child with a cardiac murmur", section on 'Third and fourth heart sounds'</a> and  <a class="medical medical_review" href="/d/html/103723.html" rel="external">"Approach to the infant or child with a cardiac murmur", section on 'Other sounds'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Early systolic clicks, which occur with semilunar valve stenosis (<a class="graphic graphic_movie graphicRef104791" href="/d/graphic/104791.html" rel="external">movie 5</a>), bicuspid aortic valve (<a class="graphic graphic_movie graphicRef104790" href="/d/graphic/104790.html" rel="external">movie 6</a>), and truncus arteriosus.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Midsystolic clicks, which are heard with mitral valve prolapse and with Ebstein anomaly of the tricuspid valve.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An S3 gallop (<a class="graphic graphic_movie graphicRef104786" href="/d/graphic/104786.html" rel="external">movie 7</a>), which, in infants, can result from ventricular dysfunction or left ventricular volume overload.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pericardial friction rubs (<a class="graphic graphic_movie graphicRef104793" href="/d/graphic/104793.html" rel="external">movie 8</a>) occur with small to moderate pericardial effusions and pericarditis. Purulent pericarditis is an unusual complication of neonatal sepsis [<a href="#rid82">82,83</a>]. Pericarditis is also seen in neonatal lupus that may occur in infants of mothers with connective tissue disorders and anti-Ro/SSA and/or anti-La/SSB bodies [<a href="#rid84">84</a>]. (See  <a class="medical medical_review" href="/d/html/6402.html" rel="external">"Neonatal lupus: Epidemiology, pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathologic murmurs</strong> – The presence of a murmur is often associated with CHD (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a>). However, not all CHD lesions are associated with murmurs and many infants with murmurs do not have structural heart disease [<a href="#rid73">73,85</a>].</p><p></p><p class="bulletIndent1">Murmurs associated with heart disease may be distinguished from innocent murmurs based upon the intensity (<a class="graphic graphic_table graphicRef105030" href="/d/graphic/105030.html" rel="external">table 7</a>), location, and quality of the murmur and associated findings [<a href="#rid86">86-88</a>]. Features that are associated with heart disease are summarized in the table (<a class="graphic graphic_table graphicRef105035" href="/d/graphic/105035.html" rel="external">table 8</a>). If the murmur cannot confidently be ascertained as innocent, echocardiography should be performed.</p><p></p><p class="bulletIndent1">The approach to evaluating cardiac murmurs in infants and children is discussed separately. (See  <a class="medical medical_review" href="/d/html/103723.html" rel="external">"Approach to the infant or child with a cardiac murmur"</a>.)</p><p></p><p class="bulletIndent1">Many infants with CHD do not have a murmur [<a href="#rid73">73,89</a>], and, therefore, the absence of a murmur does not rule out CHD. The following factors may account for the absence of a murmur:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The velocity of turbulent blood flow may not be high enough to generate a murmur. This typically occurs in hypoplastic left heart syndrome (<a class="graphic graphic_figure graphicRef82280" href="/d/graphic/82280.html" rel="external">figure 6</a>), simple transposition of the great arteries (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>), total anomalous pulmonary venous connections (TAPVC) (<a class="graphic graphic_figure graphicRef77375" href="/d/graphic/77375.html" rel="external">figure 7</a>), pulmonary atresia, and cardiomyopathy.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Decreased ventricular function can limit the generation of a murmur. As an example, if the left ventricular myocardium cannot generate enough contraction to create sufficient flow across a critically obstructed aortic valve, a murmur of aortic stenosis will not be heard.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Elevated pulmonary resistance may limit flow. The volume or velocity of flow across a ventricular septal defect may not be sufficient to be audible until the resistance has fallen [<a href="#rid85">85</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hepatomegaly</strong> – In newborns, the liver edge normally is palpated 1 to 3 cm below the right costal margin. An enlarged liver is a nonspecific finding that may be seen in infants with heart failure and increased central venous pressure. (See  <a class="medical medical_review" href="/d/html/4984.html" rel="external">"Assessment of the newborn infant", section on 'Palpation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diminished pulses in the lower extremities</strong> – Assessment of symmetric peripheral arterial pulses is an essential part of the neonatal evaluation. The diagnosis of coarctation of the aorta (COA) (<a class="graphic graphic_figure graphicRef103747" href="/d/graphic/103747.html" rel="external">figure 4</a>) or other aortic arch obstruction (<a class="graphic graphic_figure graphicRef103748" href="/d/graphic/103748.html" rel="external">figure 5</a>) is strongly suggested in the infant with decreased or absent pulses in the lower extremities with strong upper extremity pulses, or blood pressure ≥10 mmHg higher in the arms than legs. (See  <a class="medical medical_review" href="/d/html/5760.html" rel="external">"Clinical manifestations and diagnosis of coarctation of the aorta", section on 'Manifestations according to age'</a>.)</p><p></p><p class="bulletIndent1">When measuring upper and lower extremity blood pressure in neonates, it is important to ensure that the cuff size is appropriate and that the infant is in the same state (ideally, sleeping or in a quiet awake state) during all measurements. (See  <a class="medical medical_review" href="/d/html/5001.html" rel="external">"Etiology, clinical features, and diagnosis of neonatal hypertension", section on 'Measurement'</a>.)</p><p></p><p class="bulletIndent1">Infants with significant COA may have cool and/or mottled lower extremities that must be distinguished from cutis marmorata (<a class="graphic graphic_picture graphicRef50846" href="/d/graphic/50846.html" rel="external">picture 1</a>), a purplish, marble-like mottling that appears with exposure to cold [<a href="#rid67">67</a>]. Cutis marmorata is probably caused by constriction of the small cutaneous arterioles, causing the small venules to appear prominent. It is not usually limited to the lower extremities and disappears once the infant is warm. COA should also be considered in the differential diagnosis of neonatal hypertension [<a href="#rid90">90</a>]. (See  <a class="medical medical_review" href="/d/html/5001.html" rel="external">"Etiology, clinical features, and diagnosis of neonatal hypertension"</a>.)</p><p></p><p class="bulletIndent1">Some cases of COA escape early diagnosis [<a href="#rid91">91</a>]. In the study of the utility of routine examinations to detect CHD cited above, 19 of 95 (20 percent) infants diagnosed with COA by 12 months of age were not diagnosed before 12 weeks of age [<a href="#rid72">72</a>]. (See <a class="local">'Late presentation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Extracardiac abnormalities</strong> – Extracardiac abnormalities are frequently detected in children with CHD, and CHD may be a component of many specific syndromes and chromosomal disorders (<a class="graphic graphic_table graphicRef81423" href="/d/graphic/81423.html" rel="external">table 3</a>) [<a href="#rid38">38</a>]. Infants with genetic disorders associated with cardiovascular malformations (<a class="graphic graphic_table graphicRef81423" href="/d/graphic/81423.html" rel="external">table 3</a>) should be evaluated for possible cardiac abnormalities. Skeletal abnormalities, especially those of the hand and arm, are often associated with cardiac malformations.</p><p></p><p class="bulletIndent1">In the available reports, approximately 20 percent of children with CHD had noncardiac abnormalities and 7 to 12 percent had an identifiable syndrome or chromosomal disorder [<a href="#rid33">33,92,93</a>].</p><p></p><p class="headingAnchor" id="H2707728"><span class="h4">Pulse oximetry screening</span><span class="headingEndMark"> — </span>Universal newborn screening with pulse oximetry improves the identification of patients with critical CHD compared with physical examination alone [<a href="#rid8">8,78,94-98</a>]. The strategy of universal newborn screening is endorsed by the AAP, AHA, Health and Human Services (HHS), and ACCF [<a href="#rid77">77,99,100</a>]. In the United States, nearly all states require mandatory newborn screening for critical CHD [<a href="#rid101">101</a>].</p><p>The approach to newborn screening for critical CHD using pulse oximetry is summarized in the figure and is discussed in detail separately (<a class="graphic graphic_algorithm graphicRef139676" href="/d/graphic/139676.html" rel="external">algorithm 1</a>). (See  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p class="headingAnchor" id="H2707791"><span class="h2">Late presentation</span><span class="headingEndMark"> — </span>Clinicians should be alert to clinical manifestations of CHD that may be detected in the course of initial routine newborn visits because some neonates with critical CHD are asymptomatic during the birth hospitalization and then develop signs and symptoms after discharge, typically by two weeks of age [<a href="#rid61">61,72,73</a>]. (See <a class="local">'Late presentation'</a> above.)</p><p class="headingAnchor" id="H2707805"><span class="h3">Evaluation</span><span class="headingEndMark"> — </span>The evaluation for CHD in an infant includes (see <a class="local">'Physical examination'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span>General assessment (including weight).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Measurement of heart rate and upper and lower extremity blood pressure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Detailed cardiac examination (including auscultation for murmurs and/or abnormal heart sounds). In some infants with CHD, murmurs may not be heard during the initial examination but may be detected at or beyond the age of six weeks [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Palpation of the liver edge (to assess for hepatomegaly).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assessment of peripheral pulses.</p><p></p><p>In addition, primary care providers should ascertain whether pulse oximetry screening was performed during the birth hospitalization and, if not, perform screening in the office setting. (See <a class="local">'Pulse oximetry screening'</a> above and  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p>Measurement of upper and lower extremity blood pressure and assessment of peripheral pulses are particularly important. Diminished and absent peripheral pulses are findings consistent with the diagnosis of COA (<a class="graphic graphic_figure graphicRef103747" href="/d/graphic/103747.html" rel="external">figure 4</a>), which is frequently delayed. The importance of physical examination findings in detecting newborns with COA was highlighted in a study of 90 infants with critical COA, 19 (21 percent) of whom were born at centers with pulse oximetry screening [<a href="#rid74">74</a>]. One-half of the neonates were discharged from the birth hospital undiagnosed, and nearly one-half of the discharged infants were later readmitted for circulatory failure (one infant died at home). Clinical findings suggestive of COA (ie, systolic cardiac murmur and/or weak femoral pulses) had been noted in 17 (37 percent) of the discharged infants. In a study from the United Kingdom of all infants with CHD diagnosed before 12 months of age, 27 and 20 percent of infants with coarctation remained undiagnosed by six weeks and three months, respectively [<a href="#rid72">72</a>]. (See  <a class="medical medical_review" href="/d/html/5760.html" rel="external">"Clinical manifestations and diagnosis of coarctation of the aorta", section on 'Manifestations according to age'</a>.)</p><p class="headingAnchor" id="H608477631"><span class="h3">When to refer</span><span class="headingEndMark"> — </span>For infants seen in the office setting by primary care providers, consultation or referral to a pediatric cardiologist should be made if any of the following are noted:</p><p class="bulletIndent1"><span class="glyph">●</span>Signs or symptoms concerning for CHD, including cyanosis, respiratory symptoms, difficulty feeding, or poor weight gain. (See <a class="local">'Cyanosis'</a> above and <a class="local">'Respiratory symptoms'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Physical examination findings suggestive of CHD (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a> and <a class="graphic graphic_table graphicRef105035" href="/d/graphic/105035.html" rel="external">table 8</a>), including abnormal precordial activity, abnormal heart sounds (eg, S3 gallop, click, or single S2), pathologic murmur, abnormal four extremity blood pressure (ie, blood pressure ≥10 mmHg higher in the arms than legs), or diminished or absent lower extremity pulses. (See <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Positive pulse oximetry screening. (See <a class="local">'Pulse oximetry screening'</a> above and  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Genetic disorder or extracardiac abnormality associated with cardiovascular malformations (<a class="graphic graphic_table graphicRef81423" href="/d/graphic/81423.html" rel="external">table 3</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal chest radiograph or ECG (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a>).</p><p></p><p class="headingAnchor" id="H1450040079"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>There are many other diagnostic considerations when evaluating a neonate with suspected CHD. The differential diagnosis varies depending on the chief clinical findings (shock, cyanosis, or respiratory distress). The history, cardiovascular examination, chest radiograph, laboratory testing, and, ultimately, echocardiography distinguish CHD from noncardiac conditions. (See <a class="local">'Diagnostic approach'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Shock</strong> – Sepsis is the most common cause of neonatal shock. Other important causes are summarized in the table (<a class="graphic graphic_table graphicRef110373" href="/d/graphic/110373.html" rel="external">table 9</a>). A cardiac etiology of shock may be suggested based on a finding of cardiomegaly on chest radiograph and/or lack of improvement or clinical deterioration in response to volume resuscitation. Causes of neonatal shock and the diagnostic evaluation are discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/5039.html" rel="external">"Neonatal shock: Etiology, clinical manifestations, and evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cyanosis</strong> – Noncardiac conditions that can cause cyanosis include (<a class="graphic graphic_table graphicRef50161" href="/d/graphic/50161.html" rel="external">table 10</a>) (see  <a class="medical medical_review" href="/d/html/14305.html" rel="external">"Approach to cyanosis in the newborn"</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pulmonary disorders are the most common cause of cyanosis and include structural abnormalities of the lung, ventilation-perfusion mismatching due to respiratory distress syndrome, congenital or acquired airway obstruction, pneumothorax, and hypoventilation. (See  <a class="medical medical_review" href="/d/html/4964.html" rel="external">"Overview of neonatal respiratory distress and disorders of transition"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Abnormal forms of hemoglobin (eg, methemoglobin) can result in cyanosis, and polycythemic infants may appear cyanotic even if they are adequately oxygenated. (See  <a class="medical medical_review" href="/d/html/7164.html" rel="external">"Hemoglobin variants that alter hemoglobin-oxygen affinity"</a> and  <a class="medical medical_review" href="/d/html/5940.html" rel="external">"Neonatal polycythemia"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Poor peripheral perfusion with cyanosis may result from sepsis, hypoglycemia, dehydration, and hypoadrenalism.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Right-to-left shunting through the ductus arteriosus, resulting in differences in oxygen saturation measured in the arm (preductal) and leg (postductal), can occur with primary or persistent pulmonary hypertension [<a href="#rid102">102</a>]. (See  <a class="medical medical_review" href="/d/html/5045.html" rel="external">"Persistent pulmonary hypertension of the newborn (PPHN): Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acrocyanosis refers to bluish color in the hands, feet, and around the mouth (circumoral cyanosis). The mucus membranes generally remain pink. Acrocyanosis usually reflects benign vasomotor changes in the diffuse venous structures in the affected areas. It does not indicate pathology unless cardiac output is extremely low, resulting in cutaneous vasoconstriction [<a href="#rid67">67</a>]. (See  <a class="medical medical_review" href="/d/html/14305.html" rel="external">"Approach to cyanosis in the newborn", section on 'Peripheral versus central cyanosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory symptoms</strong> – Tachypnea in a newborn is most commonly due to disorders of transition (eg, transient tachypnea of the newborn, respiratory distress syndrome). Other pulmonary etiologies include pneumonia, pneumothorax, congenital diaphragmatic hernia, tracheoesophageal fistula, and congenital pulmonary airway malformation. Neonates with cardiac tachypnea frequently lack increased work of breathing at rest (sometimes referred to as "happy" or "comfortable" tachypnea), and they become more distressed with feeding. In contrast, neonates with primary pulmonary disorders often appear distressed both at rest and with activity. Cough and wheeze are also more likely to be of pulmonary etiology, but they can occur with CHD. While these findings may suggest a cardiac or pulmonary etiology, further investigation including physical examination, pulse oximetry, chest radiography, and, ultimately, echocardiography are required to make the distinction. (See <a class="local">'Diagnostic approach'</a> above and  <a class="medical medical_review" href="/d/html/4964.html" rel="external">"Overview of neonatal respiratory distress and disorders of transition"</a>.)</p><p></p><p class="headingAnchor" id="H3405783662"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/115414.html" rel="external">"Society guideline links: Congenital heart disease in infants and children"</a>.)</p><p class="headingAnchor" id="H765036"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence </strong>– Congenital heart disease (CHD) is the most common type of congenital anomaly, with an overall prevalence of approximately 1 percent. Critical CHD, defined as lesions requiring surgery or catheter-based intervention in the first year of life, accounts for approximately 25 percent of CHD and is a leading causes of infant mortality. The risk of morbidity and mortality increases when there is a delay in diagnosis and treatment. (See <a class="local">'Epidemiology'</a> above and <a class="local">'Terminology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – The risk of CHD is increased in infants who have a history of maternal medical conditions or prenatal disorders associated with CHD, positive family history (<a class="graphic graphic_table graphicRef103088" href="/d/graphic/103088.html" rel="external">table 2</a>), or extracardiac anomalies (<a class="graphic graphic_table graphicRef81423" href="/d/graphic/81423.html" rel="external">table 3</a>). When present, these factors should increase the vigilance of the clinician for the possibility of CHD in the newborn infant. (See <a class="local">'Risk factors'</a> above and <a class="local">'History'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulse oximetry screening</strong> – Pulse oximetry screening for critical CHD is suggested for all newborns, as summarized in the algorithm (<a class="graphic graphic_algorithm graphicRef139676" href="/d/graphic/139676.html" rel="external">algorithm 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p></p><p class="bulletIndent1">However, screening does not detect all critical CHD lesions, particularly noncyanotic lesions and some left heart obstructive lesions. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features of critical CHD</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Early presentation </strong>– Neonates can present during the birth hospitalization with serious and life-threatening manifestations, including (see <a class="local">'Early presentation'</a> above): </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Shock (see <a class="local">'Shock'</a> above)</p><p class="bulletIndent3"><span class="glyph">-</span>Cyanosis, or (see <a class="local">'Cyanosis'</a> above)</p><p class="bulletIndent3"><span class="glyph">-</span>Respiratory distress (see <a class="local">'Respiratory symptoms'</a> above)</p><p></p><p class="bulletIndent2">However, some newborns with critical CHD, particularly those with ductal-dependent lesions (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>), may initially have no or very subtle signs and symptoms. (See <a class="local">'Postnatal diagnosis'</a> above and <a class="local">'Asymptomatic neonates'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Ductal-dependent lesions</strong> – In patients with ductal-dependent lesions (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>), closure of the ductus arteriosus (<a class="graphic graphic_figure graphicRef65828" href="/d/graphic/65828.html" rel="external">figure 1</a>) within the first few days of life can precipitate rapid clinical deterioration with potentially life-threatening consequences. Initiation of prostaglandin E1 to reopen or maintain the ductus arteriosus can be lifesaving in these patients and should be initiated as soon as CHD is suspected, as discussed separately. (See  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Prostaglandin E1'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Late presentation</strong> – Because some neonates with critical CHD may not be identified during the birth hospitalization, clinicians should be aware and look for clinical manifestations of CHD during the first postdischarge visit. Symptoms are nonspecific and include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Feeding difficulties</p><p class="bulletIndent3"><span class="glyph">-</span>Poor weight gain</p><p class="bulletIndent3"><span class="glyph">-</span>Cyanosis</p><p class="bulletIndent3"><span class="glyph">-</span>Respiratory distress</p><p class="bulletIndent3"><span class="glyph">-</span>Decreased activity</p><p class="bulletIndent3"><span class="glyph">-</span>Irritability</p><p class="bulletIndent3"><span class="glyph">-</span>Excessive sweating </p><p></p><p class="bulletIndent2">The routine examination should include global assessment (including weight), measurement of heart rate and upper and lower extremity blood pressure, detailed cardiac examination (including auscultation for murmurs and/or abnormal heart sounds), palpation of the liver, and assessment of peripheral pulses. (See <a class="local">'Late presentation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Physical examination findings</strong> – Physical findings that are suggestive of CHD include (<a class="graphic graphic_table graphicRef105035" href="/d/graphic/105035.html" rel="external">table 8</a>) (see <a class="local">'Physical examination'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Abnormal heart rate or rhythm</p><p class="bulletIndent3"><span class="glyph">-</span>Pathologic murmurs</p><p class="bulletIndent3"><span class="glyph">-</span>Diminished/absent peripheral pulses or blood pressure ≥10 mmHg higher in the arms than legs</p><p class="bulletIndent3"><span class="glyph">-</span>Abnormal heart sounds (eg, third heart sound [S3] gallop, click, or single second heart sound [S2])</p><p class="bulletIndent3"><span class="glyph">-</span>Extracardiac anomalies</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – The diagnostic evaluation of neonates with suspected CHD includes (see <a class="local">'Diagnostic approach'</a> above): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Physical examination</p><p class="bulletIndent2"><span class="glyph">•</span>Pulse oximetry</p><p class="bulletIndent2"><span class="glyph">•</span>Chest radiograph</p><p class="bulletIndent2"><span class="glyph">•</span>Electrocardiogram (ECG)</p><p class="bulletIndent2"><span class="glyph">•</span>Echocardiography</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Referral</strong> – Urgent referral to a pediatric cardiologist for consultation and echocardiography should be made for infants with any of the following (see <a class="local">'When to refer'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Signs and symptoms concerning for critical CHD, including shock unresponsive to volume resuscitation, cardiomegaly, cyanosis, pulmonary edema, or otherwise unexplained respiratory symptoms. (See <a class="local">'Shock'</a> above and <a class="local">'Cyanosis'</a> above and <a class="local">'Respiratory symptoms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>ECG, and/or chest radiograph findings suggestive of CHD (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a>). (See  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Electrocardiogram'</a> and  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Chest radiograph'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Physical examination findings suggestive of CHD (<a class="graphic graphic_table graphicRef79941" href="/d/graphic/79941.html" rel="external">table 4</a> and <a class="graphic graphic_table graphicRef105035" href="/d/graphic/105035.html" rel="external">table 8</a>), including abnormal heart sounds (eg, third heart sound [S3] gallop, click, or single second heart sound [S2]), pathologic murmur (loud, holosystolic, diastolic, or loudest at apex or upper left or right sternal border), diminished or absent lower extremity pulses, or blood pressure ≥10 mmHg higher in the arms than legs. (See <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Positive pulse oximetry screening (<a class="graphic graphic_algorithm graphicRef139676" href="/d/graphic/139676.html" rel="external">algorithm 1</a>). (See <a class="local">'Pulse oximetry screening'</a> above and  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Genetic disorder or extracardiac malformation associated with cardiovascular malformations. Abnormal findings on echocardiogram (<a class="graphic graphic_table graphicRef81423" href="/d/graphic/81423.html" rel="external">table 3</a>).</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Tennant PW, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital anomalies: a population-based study. Lancet 2010; 375:649.</a></li><li><a class="nounderline abstract_t">Bird TM, Hobbs CA, Cleves MA, et al. National rates of birth defects among hospitalized newborns. Birth Defects Res A Clin Mol Teratol 2006; 76:762.</a></li><li><a class="nounderline abstract_t">Canfield MA, Honein MA, Yuskiv N, et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 2006; 76:747.</a></li><li><a class="nounderline abstract_t">Oster ME, Lee KA, Honein MA, et al. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics 2013; 131:e1502.</a></li><li><a class="nounderline abstract_t">Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed 2008; 93:F33.</a></li><li><a class="nounderline abstract_t">Gregory J, Emslie A, Wyllie J, Wren C. Examination for cardiac malformations at six weeks of age. Arch Dis Child Fetal Neonatal Ed 1999; 80:F46.</a></li><li><a class="nounderline abstract_t">Samánek M, Slavík Z, Zborilová B, et al. Prevalence, treatment, and outcome of heart disease in live-born children: a prospective analysis of 91,823 live-born children. Pediatr Cardiol 1989; 10:205.</a></li><li><a class="nounderline abstract_t">Peterson C, Ailes E, Riehle-Colarusso T, et al. Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetry. JAMA Pediatr 2014; 168:361.</a></li><li><a class="nounderline abstract_t">Martin GR, Schwartz BN, Hom LA, Donofrio MT. Lessons Learned from Infants with Late Detection of Critical Congenital Heart Disease. Pediatr Cardiol 2022; 43:580.</a></li><li><a class="nounderline abstract_t">Kuehl KS, Loffredo CA, Ferencz C. Failure to diagnose congenital heart disease in infancy. Pediatrics 1999; 103:743.</a></li><li><a class="nounderline abstract_t">Eckersley L, Sadler L, Parry E, et al. Timing of diagnosis affects mortality in critical congenital heart disease. Arch Dis Child 2016; 101:516.</a></li><li><a class="nounderline abstract_t">Morris SA, Ethen MK, Penny DJ, et al. Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome. Circulation 2014; 129:285.</a></li><li><a class="nounderline abstract_t">Wu MH, Chen HC, Lu CW, et al. Prevalence of congenital heart disease at live birth in Taiwan. J Pediatr 2010; 156:782.</a></li><li><a class="nounderline abstract_t">Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985; 121:31.</a></li><li><a class="nounderline abstract_t">Tanner K, Sabrine N, Wren C. Cardiovascular malformations among preterm infants. Pediatrics 2005; 116:e833.</a></li><li><a class="nounderline abstract_t">Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008; 153:807.</a></li><li><a class="nounderline abstract_t">Wren C, Irving CA, Griffiths JA, et al. Mortality in infants with cardiovascular malformations. Eur J Pediatr 2012; 171:281.</a></li><li><a class="nounderline abstract_t">Ishikawa T, Iwashima S, Ohishi A, et al. Prevalence of congenital heart disease assessed by echocardiography in 2067 consecutive newborns. Acta Paediatr 2011; 100:e55.</a></li><li><a class="nounderline abstract_t">Khoshnood B, Lelong N, Houyel L, et al. Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart 2012; 98:1667.</a></li><li><a class="nounderline abstract_t">Liu S, Joseph KS, Lisonkova S, et al. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Circulation 2013; 128:583.</a></li><li><a class="nounderline abstract_t">Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39:1890.</a></li><li><a class="nounderline abstract_t">Boneva RS, Botto LD, Moore CA, et al. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001; 103:2376.</a></li><li><a class="nounderline abstract_t">Rosano A, Botto LD, Botting B, Mastroiacovo P. Infant mortality and congenital anomalies from 1950 to 1994: an international perspective. J Epidemiol Community Health 2000; 54:660.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Trends in infant mortality attributable to birth defects--United States, 1980-1995. MMWR Morb Mortal Wkly Rep 1998; 47:773.</a></li><li><a class="nounderline abstract_t">Mahle WT, Sutherland JL, Frias PA. Outcome of isolated bicuspid aortic valve in childhood. J Pediatr 2010; 157:445.</a></li><li><a class="nounderline abstract_t">Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol 2010; 55:2789.</a></li><li><a class="nounderline abstract_t">Basso C, Boschello M, Perrone C, et al. An echocardiographic survey of primary school children for bicuspid aortic valve. Am J Cardiol 2004; 93:661.</a></li><li><a class="nounderline abstract_t">van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011; 58:2241.</a></li><li><a class="nounderline abstract_t">Schwedler G, Lindinger A, Lange PE, et al. Frequency and spectrum of congenital heart defects among live births in Germany : a study of the Competence Network for Congenital Heart Defects. Clin Res Cardiol 2011; 100:1111.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001. MMWR Morb Mortal Wkly Rep 2006; 54:1301.</a></li><li><a class="nounderline abstract_t">Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115:2995.</a></li><li><a class="nounderline abstract_t">Yokouchi-Konishi T, Yoshimatsu J, Sawada M, et al. Recurrent Congenital Heart Diseases Among Neonates Born to Mothers with Congenital Heart Diseases. Pediatr Cardiol 2019; 40:865.</a></li><li><a class="nounderline abstract_t">Øyen N, Poulsen G, Boyd HA, et al. Recurrence of congenital heart defects in families. Circulation 2009; 120:295.</a></li><li><a class="nounderline abstract_t">Brodwall K, Greve G, Leirgul E, et al. Recurrence of congenital heart defects among siblings-a nationwide study. Am J Med Genet A 2017; 173:1575.</a></li><li><a class="nounderline abstract_t">Peyvandi S, Ingall E, Woyciechowski S, et al. Risk of congenital heart disease in relatives of probands with conotruncal cardiac defects: an evaluation of 1,620 families. Am J Med Genet A 2014; 164A:1490.</a></li><li><a class="nounderline abstract_t">Hales AR, Mahle WT. Echocardiography screening of siblings of children with bicuspid aortic valve. Pediatrics 2014; 133:e1212.</a></li><li><a class="nounderline abstract_t">Cowan JR, Ware SM. Genetics and genetic testing in congenital heart disease. Clin Perinatol 2015; 42:373.</a></li><li><a class="nounderline abstract_t">Pierpont ME, Basson CT, Benson DW Jr, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115:3015.</a></li><li><a class="nounderline abstract_t">Pierpont ME, Brueckner M, Chung WK, et al. Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association. Circulation 2018; 138:e653.</a></li><li><a class="nounderline abstract_t">Øyen N, Diaz LJ, Leirgul E, et al. Prepregnancy Diabetes and Offspring Risk of Congenital Heart Disease: A Nationwide Cohort Study. Circulation 2016; 133:2243.</a></li><li><a class="nounderline abstract_t">Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271:146.</a></li><li><a class="nounderline abstract_t">Pinelli JM, Symington AJ, Cunningham KA, Paes BA. Case report and review of the perinatal implications of maternal lithium use. Am J Obstet Gynecol 2002; 187:245.</a></li><li><a class="nounderline abstract_t">Löser H, Majewski F. Type and frequency of cardiac defects in embryofetal alcohol syndrome. Report of 16 cases. Br Heart J 1977; 39:1374.</a></li><li><a class="nounderline abstract_t">Alverson CJ, Strickland MJ, Gilboa SM, Correa A. Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics 2011; 127:e647.</a></li><li><a class="nounderline abstract_t">Sullivan PM, Dervan LA, Reiger S, et al. Risk of congenital heart defects in the offspring of smoking mothers: a population-based study. J Pediatr 2015; 166:978.</a></li><li><a class="nounderline abstract_t">Shamshirsaz AA, Bateni ZH, Sangi-Haghpeykar H, et al. Cyanotic congenital heart disease following fertility treatments in the United States from 2011 to 2014. Heart 2018; 104:945.</a></li><li><a class="nounderline abstract_t">Reefhuis J, Honein MA, Schieve LA, et al. Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod 2009; 24:360.</a></li><li><a class="nounderline abstract_t">Oster ME, Riehle-Colarusso T, Alverson CJ, Correa A. Associations between maternal fever and influenza and congenital heart defects. J Pediatr 2011; 158:990.</a></li><li><a class="nounderline abstract_t">International Society of Ultrasound in Obstetrics and Gynecology, Carvalho JS, Allan LD, et al. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol 2013; 41:348.</a></li><li><a class="nounderline abstract_t">Friedberg MK, Silverman NH, Moon-Grady AJ, et al. Prenatal detection of congenital heart disease. J Pediatr 2009; 155:26.</a></li><li><a class="nounderline abstract_t">Hill GD, Block JR, Tanem JB, Frommelt MA. Disparities in the prenatal detection of critical congenital heart disease. Prenat Diagn 2015; 35:859.</a></li><li><a class="nounderline abstract_t">Quartermain MD, Pasquali SK, Hill KD, et al. Variation in Prenatal Diagnosis of Congenital Heart Disease in Infants. Pediatrics 2015; 136:e378.</a></li><li><a class="nounderline abstract_t">van Velzen CL, Ket JCF, van de Ven PM, et al. Systematic review and meta-analysis of the performance of second-trimester screening for prenatal detection of congenital heart defects. Int J Gynaecol Obstet 2018; 140:137.</a></li><li><a class="nounderline abstract_t">van Nisselrooij AEL, Teunissen AKK, Clur SA, et al. Why are congenital heart defects being missed? Ultrasound Obstet Gynecol 2020; 55:747.</a></li><li><a class="nounderline abstract_t">Sun HY, Proudfoot JA, McCandless RT. Prenatal detection of critical cardiac outflow tract anomalies remains suboptimal despite revised obstetrical imaging guidelines. Congenit Heart Dis 2018; 13:748.</a></li><li><a class="nounderline abstract_t">Lopez KN, Baker-Smith C, Flores G, et al. Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association. J Am Heart Assoc 2022; 11:e025358.</a></li><li><a class="nounderline abstract_t">Krishnan A, Jacobs MB, Morris SA, et al. Impact of Socioeconomic Status, Race and Ethnicity, and Geography on Prenatal Detection of Hypoplastic Left Heart Syndrome and Transposition of the Great Arteries. Circulation 2021; 143:2049.</a></li><li><a class="nounderline abstract_t">Hoffman JI. It is time for routine neonatal screening by pulse oximetry. Neonatology 2011; 99:1.</a></li><li><a class="nounderline abstract_t">Liberman RF, Getz KD, Lin AE, et al. Delayed diagnosis of critical congenital heart defects: trends and associated factors. Pediatrics 2014; 134:e373.</a></li><li><a class="nounderline abstract_t">Schultz AH, Localio AR, Clark BJ, et al. Epidemiologic features of the presentation of critical congenital heart disease: implications for screening. Pediatrics 2008; 121:751.</a></li><li><a class="nounderline abstract_t">Chang RK, Gurvitz M, Rodriguez S. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med 2008; 162:969.</a></li><li class="breakAll">Danford DA, McNamara DG. Infants with congenital heart disease in the first year of life. In: The Science and Practice of Pediatric Cardiology, Garson A, Bricker JT, Fisher DJ, Neish SR (Eds), Williams &amp; Wilkins, Baltimore 1998. p.2228.</li><li><a class="nounderline abstract_t">Pickert CB, Moss MM, Fiser DH. Differentiation of systemic infection and congenital obstructive left heart disease in the very young infant. Pediatr Emerg Care 1998; 14:263.</a></li><li><a class="nounderline abstract_t">Lees MH. Cyanosis of the newborn infant. Recognition and clinical evaluation. J Pediatr 1970; 77:484.</a></li><li><a class="nounderline abstract_t">Abu-Harb M, Wyllie J, Hey E, et al. Presentation of obstructive left heart malformations in infancy. Arch Dis Child Fetal Neonatal Ed 1994; 71:F179.</a></li><li class="breakAll">Ward KE, Mullins CE. Anomalous pulmonary venous connections, pulmonary vein stenosis, and atresia of the common pulmonary vein. In: The Science and Practice of Pediatric Cardiology, Garson A, Bricker JT, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998. p.1445.</li><li class="breakAll">Duff FD, McNamara DG. History and physical examination of the cardiovascular system. In: The Science and Practice of Pediatric Cardiology, Garson A, Bricker JT, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998. p.693.</li><li><a class="nounderline abstract_t">Moss AJ, McDonald LV. Cardiac disease in the wheezing child. Chest 1977; 71:187.</a></li><li><a class="nounderline abstract_t">Ledwith MV, Duff DF. A review of vascular rings 1980-1992. Ir Med J 1994; 87:178.</a></li><li><a class="nounderline abstract_t">Go RO, Martin TR, Lester MR. A wheezy infant unresponsive to bronchodilators. Ann Allergy Asthma Immunol 1997; 78:449.</a></li><li><a class="nounderline abstract_t">Singer JI, Isaacman DJ, Bell LM. The wheezer that wasn't. Pediatr Emerg Care 1992; 8:107.</a></li><li><a class="nounderline abstract_t">Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child Fetal Neonatal Ed 1999; 80:F49.</a></li><li><a class="nounderline abstract_t">Ainsworth S, Wyllie JP, Wren C. Prevalence and clinical significance of cardiac murmurs in neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80:F43.</a></li><li><a class="nounderline abstract_t">Lannering K, Bartos M, Mellander M. Late Diagnosis of Coarctation Despite Prenatal Ultrasound and Postnatal Pulse Oximetry. Pediatrics 2015; 136:e406.</a></li><li><a class="nounderline abstract_t">Aisenberg RB, Rosenthal A, Nadas AS, Wolff PH. Developmental delay in infants with congenital heart disease. Correlation with hypoxemia and congestive heart failure. Pediatr Cardiol 1982; 3:133.</a></li><li><a class="nounderline abstract_t">Campbell RM, Douglas PS, Eidem BW, et al. ACC/AAP/AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 appropriate use criteria for initial transthoracic echocardiography in outpatient pediatric cardiology: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol 2014; 64:2039.</a></li><li><a class="nounderline abstract_t">Mahle WT, Martin GR, Beekman RH 3rd, et al. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics 2012; 129:190.</a></li><li><a class="nounderline abstract_t">de-Wahl Granelli A, Wennergren M, Sandberg K, et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ 2009; 338:a3037.</a></li><li class="breakAll">Garson A. The electrocardiogram in infants and children: a systematic approach, Lea &amp; Febiger, Philadelphia 1983.</li><li><a class="nounderline abstract_t">Yabek SM. Neonatal cyanosis. Reappraisal of response to 100% oxygen breathing. Am J Dis Child 1984; 138:880.</a></li><li class="breakAll">Rowe RD, et al. Abnormalities of the cardiovascular transition of the newborn: current views on vascular and myocardial responses. In: Pediatric Cardiology, Godman MJ (Ed), Churchill Livingstone, New York 1981.</li><li><a class="nounderline abstract_t">Kanarek KS, de Brigard T, Coleman J, Silbiger ML. Purulent pericarditis in a neonate. Pediatr Infect Dis J 1991; 10:549.</a></li><li><a class="nounderline abstract_t">El Hassan N, Dbaibo G, Diab K, et al. Pseudomonas pericarditis in an immunocompetent newborn: unusual presentation with review of the literature. J Infect 2002; 44:49.</a></li><li><a class="nounderline abstract_t">White PH. Pediatric systemic lupus erythematosus and neonatal lupus. Rheum Dis Clin North Am 1994; 20:119.</a></li><li><a class="nounderline abstract_t">Rein AJ, Omokhodion SI, Nir A. Significance of a cardiac murmur as the sole clinical sign in the newborn. Clin Pediatr (Phila) 2000; 39:511.</a></li><li><a class="nounderline abstract_t">Hansen LK, Birkebaek NH, Oxhøj H. Initial evaluation of children with heart murmurs by the non-specialized paediatrician. Eur J Pediatr 1995; 154:15.</a></li><li><a class="nounderline abstract_t">McCrindle BW, Shaffer KM, Kan JS, et al. Cardinal clinical signs in the differentiation of heart murmurs in children. Arch Pediatr Adolesc Med 1996; 150:169.</a></li><li><a class="nounderline abstract_t">Smythe JF, Teixeira OH, Vlad P, et al. Initial evaluation of heart murmurs: are laboratory tests necessary? Pediatrics 1990; 86:497.</a></li><li><a class="nounderline abstract_t">MCNAMARA DG. Prevention of infant deaths from congenital heart disease. Pediatr Clin North Am 1963; 10:127.</a></li><li><a class="nounderline abstract_t">Guignard JP, Gouyon JB, Adelman RD. Arterial hypertension in the newborn infant. Biol Neonate 1989; 55:77.</a></li><li><a class="nounderline abstract_t">Ing FF, Starc TJ, Griffiths SP, Gersony WM. Early diagnosis of coarctation of the aorta in children: a continuing dilemma. Pediatrics 1996; 98:378.</a></li><li><a class="nounderline abstract_t">Hartman RJ, Rasmussen SA, Botto LD, et al. The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol 2011; 32:1147.</a></li><li><a class="nounderline abstract_t">Massin MM, Astadicko I, Dessy H. Noncardiac comorbidities of congenital heart disease in children. Acta Paediatr 2007; 96:753.</a></li><li><a class="nounderline abstract_t">Meberg A, Brügmann-Pieper S, Due R Jr, et al. First day of life pulse oximetry screening to detect congenital heart defects. J Pediatr 2008; 152:761.</a></li><li><a class="nounderline abstract_t">Riede FT, Wörner C, Dähnert I, et al. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine--results from a prospective multicenter study. Eur J Pediatr 2010; 169:975.</a></li><li><a class="nounderline abstract_t">Ewer AK, Middleton LJ, Furmston AT, et al. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet 2011; 378:785.</a></li><li><a class="nounderline abstract_t">Thangaratinam S, Brown K, Zamora J, et al. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet 2012; 379:2459.</a></li><li><a class="nounderline abstract_t">Ewer AK, Furmston AT, Middleton LJ, et al. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technol Assess 2012; 16:v.</a></li><li><a class="nounderline abstract_t">Kemper AR, Mahle WT, Martin GR, et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics 2011; 128:e1259.</a></li><li><a class="nounderline abstract_t">Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics 2009; 124:823.</a></li><li><a class="nounderline abstract_t">Glidewell J, Olney RS, Hinton C, et al. State Legislation, Regulations, and Hospital Guidelines for Newborn Screening for Critical Congenital Heart Defects - United States, 2011-2014. MMWR Morb Mortal Wkly Rep 2015; 64:625.</a></li><li><a class="nounderline abstract_t">Hoke TR, Donohue PK, Bawa PK, et al. Oxygen saturation as a screening test for critical congenital heart disease: a preliminary study. Pediatr Cardiol 2002; 23:403.</a></li></ol></div><div id="topicVersionRevision">Topic 5774 Version 60.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20092884" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 20-year survival of children born with congenital anomalies: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17063529" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : National rates of birth defects among hospitalized newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17051527" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23610203" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Temporal trends in survival among infants with critical congenital heart defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17556383" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10325812" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Examination for cardiac malformations at six weeks of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2687820" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Prevalence, treatment, and outcome of heart disease in live-born children: a prospective analysis of 91,823 live-born children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24493342" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34709442" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Lessons Learned from Infants with Late Detection of Critical Congenital Heart Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10103296" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Failure to diagnose congenital heart disease in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26130379" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Timing of diagnosis affects mortality in critical congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24135071" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20138303" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prevalence of congenital heart disease at live birth in Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3964990" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16322141" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cardiovascular malformations among preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18657826" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21748291" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Mortality in infants with cardiovascular malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21362039" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Prevalence of congenital heart disease assessed by echocardiography in 2067 consecutive newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22888161" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23812182" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Association between maternal chronic conditions and congenital heart defects: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12084585" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The incidence of congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11352887" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10942444" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Infant mortality and congenital anomalies from 1950 to 1994: an international perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9769135" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Trends in infant mortality attributable to birth defects--United States, 1980-1995.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20400103" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Outcome of isolated bicuspid aortic valve in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20579534" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Bicuspid aortic valve disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14996606" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : An echocardiographic survey of primary school children for bicuspid aortic valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22078432" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21909849" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Frequency and spectrum of congenital heart defects among live births in Germany : a study of the Competence Network for Congenital Heart Defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16397457" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17519397" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30830281" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Recurrent Congenital Heart Diseases Among Neonates Born to Mothers with Congenital Heart Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19597048" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Recurrence of congenital heart defects in families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28425218" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Recurrence of congenital heart defects among siblings-a nationwide study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24677430" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Risk of congenital heart disease in relatives of probands with conotruncal cardiac defects: an evaluation of 1,620 families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24709923" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Echocardiography screening of siblings of children with bicuspid aortic valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26042910" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Genetics and genetic testing in congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17519398" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30571578" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27166384" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Prepregnancy Diabetes and Offspring Risk of Congenital Heart Disease: A Nationwide Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8031346" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A reevaluation of risk of in utero exposure to lithium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12114921" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Case report and review of the perinatal implications of maternal lithium use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/603740" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Type and frequency of cardiac defects in embryofetal alcohol syndrome. Report of 16 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21357347" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25578997" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Risk of congenital heart defects in the offspring of smoking mothers: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29146625" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Cyanotic congenital heart disease following fertility treatments in the United States from 2011 to 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19010807" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Assisted reproductive technology and major structural birth defects in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21256509" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Associations between maternal fever and influenza and congenital heart defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23460196" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19394031" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Prenatal detection of congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25989740" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Disparities in the prenatal detection of critical congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26216324" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Variation in Prenatal Diagnosis of Congenital Heart Disease in Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29094357" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Systematic review and meta-analysis of the performance of second-trimester screening for prenatal detection of congenital heart defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31131945" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Why are congenital heart defects being missed?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30022603" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Prenatal detection of critical cardiac outflow tract anomalies remains suboptimal despite revised obstetrical imaging guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35389228" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33993718" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Impact of Socioeconomic Status, Race and Ethnicity, and Geography on Prenatal Detection of Hypoplastic Left Heart Syndrome and Transposition of the Great Arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20523077" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : It is time for routine neonatal screening by pulse oximetry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25070301" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Delayed diagnosis of critical congenital heart defects: trends and associated factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18381540" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Epidemiologic features of the presentation of critical congenital heart disease: implications for screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18838650" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Missed diagnosis of critical congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18838650" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Missed diagnosis of critical congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9733248" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Differentiation of systemic infection and congenital obstructive left heart disease in the very young infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5502102" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Cyanosis of the newborn infant. Recognition and clinical evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7820713" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Presentation of obstructive left heart malformations in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7820713" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Presentation of obstructive left heart malformations in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7820713" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Presentation of obstructive left heart malformations in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/832490" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Cardiac disease in the wheezing child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7860261" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : A review of vascular rings 1980-1992.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9164357" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : A wheezy infant unresponsive to bronchodilators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1603700" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The wheezer that wasn't.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10325813" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Presentation of congenital heart disease in infancy: implications for routine examination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10325811" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Prevalence and clinical significance of cardiac murmurs in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26169432" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Late Diagnosis of Coarctation Despite Prenatal Ultrasound and Postnatal Pulse Oximetry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6185932" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Developmental delay in infants with congenital heart disease. Correlation with hypoxemia and congestive heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25277848" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : ACC/AAP/AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 appropriate use criteria for initial transthoracic echocardiography in outpatient pediatric cardiology: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22201143" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19131383" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19131383" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6383021" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Neonatal cyanosis. Reappraisal of response to 100% oxygen breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6383021" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Neonatal cyanosis. Reappraisal of response to 100% oxygen breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1876474" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Purulent pericarditis in a neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11972421" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Pseudomonas pericarditis in an immunocompetent newborn: unusual presentation with review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8153396" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Pediatric systemic lupus erythematosus and neonatal lupus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11005364" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Significance of a cardiac murmur as the sole clinical sign in the newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7895749" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Initial evaluation of children with heart murmurs by the non-specialized paediatrician.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8556121" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Cardinal clinical signs in the differentiation of heart murmurs in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2216611" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Initial evaluation of heart murmurs: are laboratory tests necessary?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13932223" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Prevention of infant deaths from congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2650749" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Arterial hypertension in the newborn infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8784360" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Early diagnosis of coarctation of the aorta in children: a continuing dilemma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21728077" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The contribution of chromosomal abnormalities to congenital heart defects: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17462066" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Noncardiac comorbidities of congenital heart disease in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18492511" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : First day of life pulse oximetry screening to detect congenital heart defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20195633" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine--results from a prospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21820732" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22554860" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22284744" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21987707" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Strategies for implementing screening for critical congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19581259" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26086632" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : State Legislation, Regulations, and Hospital Guidelines for Newborn Screening for Critical Congenital Heart Defects - United States, 2011-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12170356" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Oxygen saturation as a screening test for critical congenital heart disease: a preliminary study.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
